← FDA DRUG APPROVALS

FDA ANDA · ANDA072060

PANCURONIUM BROMIDE

Sponsor: ELKINS SINN

APPLICATION
ANDA072060
TYPE
ANDA
ORIGINAL APPROVAL
1988-03-23
LATEST ACTION
2001-09-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PANCURONIUM BROMIDEDiscontinued
PANCURONIUM BROMIDE 2MG/ML · INJECTABLE · INJECTION

Approval history

2001-09-10Manufacturing (CMC) · Supplement 16AP
2001-09-07Manufacturing (CMC) · Supplement 14AP
2000-06-29Manufacturing (CMC) · Supplement 15AP
1998-11-23Manufacturing (CMC) · Supplement 11AP
1998-11-23Manufacturing (CMC) · Supplement 12AP
1998-08-07Manufacturing (CMC) · Supplement 10AP
1993-02-19Labeling · Supplement 8AP
1992-04-13Labeling · Supplement 5AP
1991-11-26Manufacturing (CMC) · Supplement 6AP
1989-12-08Labeling · Supplement 2AP
1988-09-01Manufacturing (CMC) · Supplement 1AP
1988-03-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →